Diane Kresovich, breast cancer, cancer trial
A Desire to Help Further Cancer Research
In May 2002, a 41-year-old data communications specialist from
Pittsburgh had the startling discovery of a cancerous lump in her breast. But
fortunately for those diagnosed with breast cancer in the future, there are
patients like Diane Kresovich.
Following surgery, Diane was referred to Dr Barry
Lembersky, medical oncologist at University of Pittsburgh, Magee-Womens
Hospital, for chemotherapy. In Diane’s situation, not one treatment regimen
stood out among the many available, which is why Dr Lembersky encouraged
participation in a Phase III clinical trial to evaluate chemotherapy treatments
for Stage II breast cancer. For Diane, the answer was obvious: “I felt like if
any of these are viable treatments for me, and I could help somehow to shed
light on what works...well, I didn’t see any reason not to participate.”
Diane was assigned to receive Adriamycin®
(doxorubicin) and Cytoxan® (cyclophosphamide), followed by Taxotere®(docetaxel).
Conveniently, Diane was able to receive treatment nearby, and although going
through chemotherapy was hard, she recognized that it’s a lot easier than it
used to be.
Finished with her chemo, Diane is still in
recovery and continues treatment for her cancer, but is doing well, with a
strong support system of people behind her. She also has the satisfaction of
having made an important contribution to scientific knowledge.